Mass separation and in vitro immunological activity of membrane-fractionated polysaccharides from fruiting body and mycelium of Agaricus subrufescens

Membrane technology has been applied to separate polysaccharides from Agaricus subrufescens (ASPs). The membrane-retained fractions and unfractionated preparations have been tested for in vitro immunological activity. Both the microfiltration (MF) and ultrafiltration (UF1) membranes were able to sep...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biotechnology and bioprocess engineering 2012-08, Vol.17 (4), p.804-811
Hauptverfasser: Silveira, Douglas Bardini, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil, Celmer, Alvaro Jose, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil, Camelini, Carla Maisa, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil, Rossi, Marcio Jose, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil, Cunha Petrus, Jose Carlos, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil, de Mendonca, Margarida Matos, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil, Pinto, Aguinaldo Roberto, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil, Zanetti, Carlos Roberto, Universidade Federal de Santa Catarina, Florianopolis, SC, Brazil
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Membrane technology has been applied to separate polysaccharides from Agaricus subrufescens (ASPs). The membrane-retained fractions and unfractionated preparations have been tested for in vitro immunological activity. Both the microfiltration (MF) and ultrafiltration (UF1) membranes were able to separate high-molecular weight polysaccharides from fruiting body (ASP-FB) and submerge-fermented mycelium (ASP-SmF) extracts. All fractions showed immunostimulatory effects on RAW 264.7 macrophages, measured by TNF-α, iNOs gene expression, and NO production. In contrast, antibody and proliferation levels in B lymphoblastoid SKW 6.4 cells were significantly increased after treatment with ASP-FB, but did not with ASP-SmF preparations. The ASPs- and LPS-induced stimulation could be differentiated by the finding that polymyxin B, a specific inhibitor of LPS, did not significantly affect the immunoactivating response and proliferation activity of ASPs on macrophages and B cells, respectively. Furthermore, the ASP-FB treatment was unable to induce IL-6 production by B cells unlike LPS activation, sustaining distinct signaling pathways for ASP-FB and LPS. The overall results provided additional information about the action of ASPs on the immune system and support the membrane method to separate and concentrate high-molecular weight ASPs for immunopharmacological and biotechnological applications.
ISSN:1226-8372
1976-3816
DOI:10.1007/s12257-011-0645-y